Spectral to Launch Toraymyxin(TM)/EAA(TM) in Canada in Q1 2018
(WorldNews Canada)

Spectral to Launch Toraymyxin(TM)/EAA(TM) in Canada in Q1 2018 TORONTO, ONTARIO--(Marketwired - Dec 13, 2017) - Spectral Medical Inc., (TSX:EDT), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced that the company has entered into a distribution agreement with CASTER MEDICAL SYSTEM (`CMS`) to launch ToraymyxinTM (`PMX`) and EAATM in Canada commencing in the first quarter of 2018. CMS`s experienced sales team will promote the products in all parts of the country, with Spectral`s team contributing scientific and marketing...